Jarushka Naidoo

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  

Jarushka Naidoo
Feb 18, 2025, 18:35 | Science
Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 18, 2025, 10:44 | Science
Stephanie Saw: Our review paper on ADCs in NSCLC with AGA is out
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, reshared a post by Giannis…
Feb 11, 2025, 08:47 | Insight
Jarushka Naidoo: Phase Ib Trial on Ivonescimab with Etoposide Plus Carboplatin in 1st line ES SCLC
Jarushka Naidoo, Full Professor of Medical Oncology at the Royal College of Surgeons in Ireland, shared…
Feb 4, 2025, 08:25 | Blog
Noemi Reguart: WCLC 2025 is coming to Barcelona
Noemi Reguart, Medical Oncologist at Hospital Clinic Barcelona, shared a post on X: "WCLC 2025…
Feb 3, 2025, 11:42 | Blog
Jarushka Naidoo: A showcase of the research work of our oncology trainees across Ireland
Jarushka Naidoo, Professor of Medical Oncology and Consultant Medical Oncologist at Beaumont RCSI Cancer Centre,…
Feb 1, 2025, 16:14 | Blog
Jarushka Naidoo: Gerry Hanna's inaugural lecture as Marie Curie Chair of Radiation Oncology
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin (Ireland), Professor in RCSI and Adjunct…
Jan 29, 2025, 07:48 | Blog
How do copy no. deletions in STK11, KEAP1 and SMARCA4 impact outcomes in NSCLC?
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared a post on X: "How…
Jan 28, 2025, 06:47 | Blog
Jarushka Naidoo: Join us in creating a pan-European vision for irAE care
Jarushka Naidoo, Professor at the Royal College of Surgeons in Ireland, shared a post on…
Jan 27, 2025, 09:49 | Blog
Jarushka Naidoo: Early detection of lung cancer showcased by Beaumont Hospital
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared a post on X: "Early…
Jan 27, 2025, 08:49 | Blog
Jarushka Naidoo: Early detection of lung cancer showcased at Beaumont Hospital by Daniel J Ryan
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin and Adjunct Professor of Oncology at…
Jan 26, 2025, 12:15 | Blog
Rachel Clarke on gut microbial biomarkers in GI cancer at ASCOGI25
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared a post by Rachel Clarke, NHS…
Jan 26, 2025, 12:14 | Blog
Jarushka Naidoo: Current Landscape in Europe for Diagnosis and Management of irAEs
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared on X: "Are you a European…
Jan 25, 2025, 04:12 | Science
Jarushka Naidoo: De-Escalation Strategies With ICIs in NSCLC - Do We Already Have Enough Evidence?
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared a post on X about…
Jan 20, 2025, 17:13 | Blog
Jarushka Naidoo: Suresh S. Ramalingam on targeted therapy for early stage NSCLC
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin (Ireland), shared a post on X:…
Jan 19, 2025, 22:56 | Science
Bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab in pleural mesothelioma
Jarushka Naidoo, Professor in RCSI and Adjunct Professor of Oncology at Johns Hopkins University, shared…
Jan 14, 2025, 02:52 | Blog
ORACLE: A clonal-expression biomarker predicts stage I NSCLC outcome ⁦
Jarushka Naidoo shared on X: "ORACLE: A clonal-expression biomarker predicts stage I NSCLC outcome ⁦…
Jan 11, 2025, 10:13 | Blog
Neoadjuvant Ipilimumab, Nivolumab vs Chemotherapy in NSCLC
Jarushka Naidoo shared on X: "Neoadj Ipi, Nivo v Chemo in NSCLC 221patients, I+Nx3 v…
Jan 11, 2025, 09:45 | Blog
Jarushka Naidoo: Beaumont Hospital Unveils New 5-Year Strategy with Focus on Innovation in Cancer Care
Jarushka Naidoo shared on X: "Special day for Beaumont Hospital as a new 5yr hospital…
Jan 4, 2025, 13:45 | Science
Jarushka Naidoo: Phase II TROPICS-03 trial: Sacituzumab Govitecan (TROP2 ADC) in 2L SCLC
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), shared a recent article by…
Dec 27, 2024, 14:15 | Science
Classification of progressive disease based on PD patterns in patients treated with ICIs - JAMA Oncology
JAMA Oncology shared a recent article by Jonas Saal on X: "A modified classification of…
Dec 25, 2024, 02:57 | Insight
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), posted the following on X:…
Dec 18, 2024, 15:38 | Blog
Incidence and outcomes of molecular subtypes of EGFR+ NSCLC
Jarushka Naidoo shared on X: "Important paper on incidence and outcomes of molec subtypes of…
Dec 16, 2024, 08:33 | Insight
Jarushka Naidoo: KN867 trial shows no EFS benefit for SBRT+Pembro in NSCLC
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), posted the following on X: “ESMO…
Dec 15, 2024, 19:50 | Opinion
Kunal Jobanputra: One of the largest dataset reporting s-irAE and outcomes in NSCLC by Jarushka Naidoo
Kunal Jobanputra, Medical Oncologist at Tata Memorial Hospital, shared on X: “One of the largest…
Dec 8, 2024, 06:18 | Blog
Michaela Higgins and Gerry Hanna highlighting the unique strengths of Irish clinical trials - Cancer Trials Ireland
Cancer Trials Ireland shared a post on X: " New Podcast episode. Join Michaela Higgins…
Dec 4, 2024, 18:55 | Blog
Jarushka Naidoo: Join the ESMO Immuno24 next week in Geneva
Jarushka Naidoo shared a post by ESMO on X: "Join us for ESMO Immuno24 next week…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Dec 1, 2024, 14:23 | Insight
Beaumont RCSI Cancer Centre PsychOncology Team Was Recognized with HSE Excellence24 Award
Jarushka Naidoo, Professor at The Royal College of Surgeons in Ireland, shared on X: “Very…
Nov 25, 2024, 12:54 | Blog
Gathering Around Cancer Conference 2024
Gathering Around Cancer Conference 2024 was held from November 21-22, 2024. The twelfth edition of…
Nov 25, 2024, 08:02 | Blog
Jarushka Naidoo: Memorial Sloan Kettering Cancer Center reunion at Gathering Around Cancer 2024
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X: "Memorial Sloan…
Nov 24, 2024, 17:00 | Blog
Jarushka Naidoo: Superb Irish young investigator session at Gathering Around Cancer 2024
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X: "Superb…
Nov 20, 2024, 00:40 | Insight
Jarushka Naidoo: ‘TrialGPT:' A new chatGPT for clinical trials
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X: “‘TrialGPT:'…
Nov 17, 2024, 12:17 | Insight
Jarushka Naidoo: Do we need PCI in SCLC in the IO era?
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X about…
Nov 15, 2024, 17:12 | Insight
Jarushka Naidoo: The largest study evaluating association between specific irAEs and IO outcomes
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X about a…
Nov 10, 2024, 19:13 | Blog
Jarushka Naidoo: A superb poster presentation at SITC24 by Michael Conroy
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X: "Well done…
Nov 10, 2024, 13:16 | Blog
Highlights from the VIII ICAPEM Symposium by Jarushka Naidoo
The VIII ICAPEM Symposium, held on November 7, 2024, was a landmark event in the…
Nov 5, 2024, 17:15 | Blog
Jarushka Naidoo: Delighted to participate in ICAPEM VIII Symposium
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X: "Delighted…
Nov 5, 2024, 13:42 | Blog
Jarushka Naidoo: Clinical trial concepts in thoracic oncology at the ETOP residential workshop
Jarushka Naidoo, Thoracic oncologist at the Beaumont Hospital Dublin, shared on LinkedIn: ''Super proud of…
Nov 2, 2024, 09:28 | Blog
New €4.9m Beaumont RCSI Cancer Centre and Irish Cancer Society Partnership to Transform Lung Cancer Care in Ireland
On 30th October The Irish Cancer Society has been launched a €4.9 million lung cancer…
Oct 31, 2024, 09:03 | Insight
Jarushka Naidoo: Maintenance Pembrolizumab with or without Olaparib for Advanced Squamous NSCLC
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X about…
Oct 31, 2024, 06:27 | Blog
Averil Power: Ireland's largest ever investment in lung cancer
Averil Power, CEO of the Irish Cancer Society, shared a post on LinkedIn: "€4.9 million…
Oct 18, 2024, 15:32 | Blog
Five year outcomes of Phase II NADIM trial, summarised by Jarushka Naidoo
Jarushka Naidoo shared a post on X: "5yr outcomes Ph II NADIM trial: - - 5yr…
Oct 12, 2024, 15:06 | Insight
Jarushka Naidoo: Superb article on the secret sauce of team science
Jarushka Naidoo shared a post on X about a recent article by Itai Yanai and…
Oct 11, 2024, 17:58 | Insight
Jarushka Naidoo: Randomized Phase II Trial Osimertinib with or without Ramucirumab in 1st line EGFR+NSCLC
Jarushka Naidoo shared a post on X: "RAMOSE: Randomized Ph II Trial Osimertinib+/-Ramucirumab in 1L EGFR+…
Oct 11, 2024, 16:32 | Blog
Jarushka Naidoo: Patient Enrollment to Industry vs Federally-funded Cancer Clinical Trials
Jarushka Naidoo shared a post on X, about recent paper published in Journal of Clinical…
Oct 8, 2024, 15:29 | Insight
Jarushka Naidoo: Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab in NSCLC
Jarushka Naidoo shared a post on X: “Long-Term Outcomes 1L Ipilimumab/Nivolumab/-Chemo v Chemo in PDL1<1%…
Oct 5, 2024, 13:04 | Insight
Highlights from ILCS24 by Stephen V Liu
The 6th International Lung Cancer Summit took place as a hybrid event in Lausanne, Switzerland,…
Sep 26, 2024, 15:35 | Blog
Jarushka Naidoo: TL01 Phase III Datopotamab-Deruxtecan vs Docetaxel in second-line NSCLC
Jarushka Naidoo shared a post on X, about recent paper published in Journal of Clinical…
Sep 24, 2024, 13:32 | Insight
Jarushka Naidoo: Stage III ALK+ NSCLC - consolidation ALK TKI vs Durvalumab vs Observation
Jarushka Naidoo shared on X: "Stage III ALK+ NSCLC: consolidation ALK Tyrosine Kinase Inhibitors versus…
Sep 23, 2024, 23:56 | Blog
Jarushka Naidoo: Pleased to present at the WCLC24 on the use of proteomic signatures to identify immune-related toxicities
Jarushka Naidoo posted on LinkedIn: "I was pleased to present at the International Association for…
Sep 21, 2024, 14:46 | Blog
Jia Luo: Pathology and Biomarkers
Jia Luo, Thoracic Medical Oncologist and Cancer Researcher at Dana-Farber Cancer Institute, shared a post…
Sep 19, 2024, 04:32 | Societies
Best of ESMO24
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 18, 2024, 15:02 | Blog
Jarushka Naidoo: We are ESMO
Jarushka Naidoo shared a post on X: "As ESMO24 draws to a close… thanks to ESMO…
Sep 18, 2024, 13:13 | Insight
Jarushka Naidoo: ESMO24 Lung mini-orals
Jarushka Naidoo shared on X: "ESMO24 Lung mini-orals. Randomised phase II trial of inhaled corticosteroids…
Sep 18, 2024, 09:18 | Insight
34 Posts Not to Miss From ESMO24 Day 4
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 15, 2024, 16:26 | Societies
43 Posts Not To Miss From ESMO24 Day 2
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 15, 2024, 15:16 | Societies
Do you have a poster presentation at ESMO24?
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 14, 2024, 15:36 | Blog
Jarushka Naidoo: WCLC2024 Poster pride
Jarushka Naidoo shared a post on LinkedIn: "WCLC24 Poster pride! Well done to super fellow David…
Sep 14, 2024, 06:41 | Societies
Best of WCLC24
The WCLC24 took place at the San Diego Convention Center from September 7 to 10,…
Sep 12, 2024, 16:26 | Societies
35 posts not to miss from WCLC24 Day 4
The WCLC24 is took place at the San Diego Convention Center from September 7 to…
Sep 12, 2024, 10:06 | Blog
Rami Manochakian: The latest data in management of stage IV NSCLC at “Advancement in Oncology” event
Rami Manochakian shared a post on X: "The amazing experts Drs Narjust Florez & Jarushka Naidoo…
Sep 11, 2024, 01:59 | Societies
38 Posts Not to Miss From WCLC24 Day 3!
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 10, 2024, 13:45 | Societies
Rami Manochakian's key highlights from WCLC24
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 10, 2024, 10:47 | Insight
Gerry Hanna: Irish Lung Cancer community together at WCLC24
Gerry Hanna, Radiation Oncologist at St James’s Hospital, shared a post on X: “Great to get…
Sep 10, 2024, 05:38 | Blog
WCLC24 Social Media Ambassadors
Narjust Florez shared a post on X: "Our social media ambassadors for WCLC24. Make sure…
Sep 9, 2024, 15:30 | Societies
25 Posts Not To Miss from Day 2 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed…
Sep 9, 2024, 14:47 | Societies
Highlights from WCLC24 by Jarushka Naidoo
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 11:35 | Societies
Inside WCLC24 - Recap by Estela Rodriguez
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 07:17 | Societies
Julie Brahmer received Paul A. Bunn Scientific Award
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 8, 2024, 13:51 | Societies
20 Posts Not To Miss from Day 1 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization…
Sep 8, 2024, 12:30 | Blog
Akhil Kapoor: Survivorship in Lung Cancer - a topic less discussed
Akhil Kapoor, Medical Oncologist, Tata Memorial Hospital Varanasi,  shared a post on X: "Survivorship in Lung…
Sep 6, 2024, 11:03 | Blog
Jarushka Naidoo: Meeting Nobel Prize Winner Jim Allison at the European Congress of Immunology in Dublin
Jarushka Naidoo shared a post on LinkedIn: "Quite a thrill to present in the same…
Sep 4, 2024, 06:47 | Insight
Jarushka Naidoo: Intracranial activity of Tarlatamab in 2L SCLC in Ph I DeLLphi-300 Trial
Jarushka Naidoo shared on X: "Intracranial activity of Tarlatamab in 2L SCLC in Ph I…
Sep 3, 2024, 22:29 | Blog
Jarushka Naidoo: A privilege to hear Nobel Prize Winner Jim Allison
Jarushka Naidoo posted on X: "A privilege to hear Nobel Prize Winner Jim Allison take…
Sep 3, 2024, 16:29 | Insight
Jarushka Naidoo: Clinical + genetic factors associated with Type I diabetes from ICIs
Jarushka Naidoo shared a post on X: "Clinical + genetic factors associated with Type I diabetes…
Sep 3, 2024, 16:13 | Blog
Rami Manochakian: Educational event during WCLC24 on latest advancements in lung cancer
Rami Manochakian shared on X: “Excited to join the Oncology Brothers, great colleagues & experts,…
Sep 2, 2024, 17:17 | Insight
Jarushka Naidoo: Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials
Jarushka Naidoo shared a post on X: "Ph III KN867 trial of SBRT+concurrent/adjuvant pembrolizumab stopped early…
Sep 1, 2024, 09:48 | Insight
Phase III Keynote-789 Trial of Platinum + Pemetrexed +/- Pembrolizumab in EGFR + NSCLC
Jarushka Naidoo shared a post on X: "Phase  III Keynote-789 Trial of Platinum + Pemetrexed +/-Pembro…
Aug 31, 2024, 17:03 | Insight
Jarushka Naidoo: Meet the Cancer Immunotherapy Experts’ at event by Breakthrough Cancer Research
Jarushka Naidoo shared a post on X: “‘Meet the Cancer Immunotherapy Experts’ at a special public…
Aug 31, 2024, 09:47 | Blog
Christian Rolfo: Excellent educational experience at Swiss Oncology Summer School
Christian Rolfo, Professor of Internal Medicine -Oncology at Ohio State University Comprehensive Cancer Center,  shared…
Aug 22, 2024, 14:00 | Insight
Jarushka Naidoo: Phase II Lazertinib in EGFR+ NSCLC with CNS disease
Jarushka Naidoo shared a post on X: “Phase II Lazertinib in EGFR+ NSCLC with CNS disease,…
Aug 22, 2024, 04:59 | Blog
Honoring Jeff Weber, a giant in the field of oncology
Jeffrey S. Weber, MD, PhD, a 2016 Giants of Cancer Care awardee in Melanoma, passed…
Aug 22, 2024, 03:05 | Insight
Jarushka Naidoo: Excited to be a part of the Swiss Oncology Summer School
Jarushka Naidoo shared on LinkedIn: “Excited to be a part of the Swiss Oncology Summer…
Aug 20, 2024, 10:11 | Blog
Jarushka Naidoo: Third neoadjuvant FDA approval in NSCLC
Jarushka Naidoo posted on X: "Third neoadjuvant FDA approval in NSCLC, now for perioperative durvalumab, based…
Aug 20, 2024, 08:03 | Insight
Oncology Brothers: How the data from WCLC24 will change our clinical practice
Estela Rodriguez shared a post by Oncology Brothers on X, adding: “Excited to share the…
Aug 19, 2024, 10:15 | Blog
Eric Singhi: Can’t-miss Oncology Brothers' LIVE event at WCLC24
Eric Singhi shared a post on X by Oncology Brothers, adding: "Can’t-miss Oncology Brothers' LIVE…
Aug 16, 2024, 19:45 | Insight
Jarushka Naidoo: SYK signature predicts irAEs from adjuv ICI in melanoma
Jarushka Naidoo shared a post on X: "SYK signature predicts irAEs from adjuv ICI in melanoma…
Aug 10, 2024, 15:51 | Insight
Steroids for irAEs and ICI efficacy: analysis from 6 trials
Jarushka Naidoo shared a post on X about a recent paper by Karijn Suijkerbuijk et…
Aug 9, 2024, 14:55 | Insight
Jordi Remon: Unresolved challenges with ICB and TKIs for early stage NSCLC
Jordi Remon, a Thoracic oncologist at CIOCC Barcelona, recently posted on X: “In the current…
Aug 9, 2024, 12:23 | Blog
The 6th International Lung Cancer Summit
The 6th International Lung Cancer Summit is a hybrid conference that will be held at…
Aug 8, 2024, 10:41 | Blog
Jarushka Naidoo: Clinical presentation and outcomes of ICI-encephalitis
Jarushka Naidoo shared on X: “Pleased to share our paper on clinical presentation and outcomes…
Aug 7, 2024, 18:01 | Blog
Jarushka Naidoo: Survivorship in Lung Cancer, a great theme to usher in a new era in thoracic oncology
Jarushka Naidoo shared a post by LUNGevity Foundation on X, adding: "Survivorship in Lung Cancer,…
Aug 5, 2024, 01:55 | Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Aug 2, 2024, 13:26 | Insight
Jarushka Naidoo is driving progress in lung cancer care and treatment
Lung Cancer America shared on X: "Thank you to Dr. Jarushka Naidoo and all clinical…
Aug 1, 2024, 13:27 | Blog
Rahul Gosain: How will the data from WCLC24 impacts our day to day clinical practice
Rahul Gosain shared a post on LinkedIn: "WCLC24 ~5 weeks away! Let discuss the current…
Aug 1, 2024, 07:01 | Blog
Advice for young oncologists from Balazs Halmos
Jarushka Naidoo shared a post on X: ''Stay Curious, Remain Humble: An Oncologist’s Advice to…
Jul 30, 2024, 06:39 | Insight
Ph II KUPENG trial of Vebreltinib in Advanced MetExon14 and NSCLC
Jarushka Naidoo shared a post on X about a recent paper by Jin-Ji Yang et…
Jul 25, 2024, 00:32 | Blog
Jarushka Naidoo: Can intratumor eschericia improve OS from ICIs in NSCLC
Jarushka Naidoo shared a post on X: ''Can intratumor eschericia (E) bring immune cells to…
Jul 22, 2024, 02:59 | Blog
CtDNA Analysis on Osimertinib in FLAURA and AURA3 trials
Jarushka Naidoo shared a post on X about an article by Jhanelle Gray et al. titled…
12
All: 157 Posts: 1 - 100
Special Coverage